MyoKardia Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St set for lower open as bond yields climb; Walmart falls
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
MyoKardia (MYOK) IPO Opens 10% Higher
October 29, 2015 10:48 AM EDTToday's IPO for MyoKardia (NASDAQ: MYOK) opened for trading at $11.08 after pricing 5,437,500 shares of common stock at a public offering price of $10.00 per share.
Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as lead book-running managers. Wells Fargo Securities is acting as book-running manager. Wedbush PacGrow is acting as co-manager.
MyoKardia is a clinical stage... More
